Dr. Silverman studies the fundamental aspects of early-life commensal microbes that influence immune system development and function. He discovered that the MHC-II E molecule prevents type 1 diabetes by shaping the intestinal microbiota early in life.
Dr. Coffin’s research interests focus on the epidemiology and prevention of healthcare-associated infections in the pediatric population. She also investigates the epidemiology of pediatric respiratory viral infections, with a particular emphasis on influenza.
Dr. Zaoutis is a pediatrician trained in infectious disease and epidemiology with a robust research program focused on the epidemiology, prevention, and treatment of healthcare acquired infections; antimicrobial resistance; and antimicrobial use.
Dr. Feemster's research includes vaccine acceptance among parents and immunization providers, community-based interventions to improve vaccine uptake, neighborhood factors associated with the incidence of pertussis and influenza, and healthcare-associated respiratory infection in the pediatric ambulatory setting.
Dr. Steenhoff is medical director of the Global Health Center at Children's Hospital. He serves as a global health advocate for children, seeking to optimize mutually beneficial partnerships between clinical and academic institutions in diverse settings.
Dr. Vella is an assistant professor of Pediatrics at Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine with a primary research focus on T follicular helper cells (Tfh), chronic infections, and vaccine readiness.
Dr. Puopolo helped lead the research team that developed and validated multivariate prediction models for neonatal early-onset sepsis risk assessment. Her current research addresses the impacts of maternal immunity, perinatal antibiotic exposure, and neonatal infection on infant and childhood health.